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Introduction  
Current blood donations cannot meet the demand of blood transfusions. For that reason, it 
is needed another pathway to get it and solve the problem of lack of blood donations. One 
possibility is through recombinant  protein using Saccharomyces cerevisiae.  
Objective 
x Recombinant plasmid and genetically modified 
organism construction  hemoglobin only 
represents 4% of protein production in 
Saccharomyces cerevisiae.  
 
x Reduction of work volume  huge equipment 
imply  more costs.  
 
x Purification process  loss of hemoglobin in each 
step of separation and purification.  
 
x Culture’s medium  medium is the most sensible 
raw material 
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Analyze viability project in economic, environmental and social terms. 
Get the final conclusions of the project. 
Give some alternatives in order to improve project results 
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Social Analysis 
1 
• Hemoglobin will be used to solve the problem of lack of donations 
2 
• In Brazil there is  a good view of biotechnological products              Public perception 
3 
• 60 operators with a salary of 50 $/hour             Contribution to economic growth 
Total Capital Investment 336.375.000 $ 
Operating Cost 1.357.787.000 $/year 
Unit Production Cost 80.807 $/kg hemoglobin 
Unit Production Revenue 1.127.500 $/kg hemoglobin 
Revenues 18.945.177.000 $/year 
Payback Time 0,03 years (11 days) + 2 years 
NPV (at 7.0% interest) 82.347.000.000 $ 
Royalties 
• Use of a patented process 
Medium 
• Huge volume of fermenters 
• Current price          0.826 $/kg 
• Profitable until 16.42 $/kg 
Genetically 
Modified 
Organism 
Downstream Economic 
Waste Environment 
PROBLEM 
Lack of blood donations 
SOLUTION 
Liposomes encapsulating hemoglobin 
 Economic: profitable process 
 Environmental: “friendly”  
 Social: acceptable by community 
x Production: only cover 10% of 
current blood donations in Brazil  
 2 years for construction 
 3rd year starts production 
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Final NVP 
82.347.000.000 $ 
Profit 
1.047.000 $/kg 
hemoglobin 
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650 – 750  6.500 – 7.500 
Modify recombinant plasmid (R&D) 
 
 
 Increase biomass concentration (R&D) 
 
 
 Recirculation 
 
 
 Develop new culture’s medium (R&D) 
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